Thyrocare Technologies has enclosed a copy of the presentation to be shared during the earnings conference call with analysts and investors, scheduled to be held today, i.e., January 28, 2026, at 5:30 PM (IST), on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The same is also being made available on the Company’s website https://investor.thyrocare.com/.
The above information is a part of company’s filings submitted to BSE.
